Concepedia

Hildo C. Lantermans

HC

Statistics

Publications

4

Citations

151

H-Index

4

Active since

2016

Affiliations

Amsterdam University Medical Centers(Current)

University of Amsterdam

Cancer Center Amsterdam

Amsterdam Neuroscience

Lymphoma Study Association

Hildo C. Lantermans is an author at Amsterdam University Medical Centers specializing in oncology, life sciences, and cell signaling.

Publications per year

2016–2023

4

Publications

4

The CXCL12gamma chemokine immobilized by heparan sulfate on stromal niche cells controls adhesion and mediates drug resistance in multiple myeloma

Zemin Ren, Hildo C. Lantermans, Annemieke Kuil et al. · Journal of Hematology & Oncology · 2021 · 76 citations · Full text

Medicine, Cell Biology, Oncology +16

Oligonucleotide-directed mutagenesis screen to identify pathogenic Lynch syndrome-associated <i>MSH2</i> DNA mismatch repair gene variants

Hellen Houlleberghs, Marleen Dekker, Hildo C. Lantermans et al. · Proceedings of the National Academy of Sciences · 2016 · 37 citations · Full text

Life Sciences, Genetics, Molecular Genetics +17

MALT1-dependent cleavage of CYLD promotes NF-κB signaling and growth of aggressive B-cell receptor-dependent lymphomas

Marthe Minderman, Hildo C. Lantermans, Leonie J. Grüneberg et al. · Blood Cancer Journal · 2023 · 25 citations · Full text

Life Sciences, Molecular Biology, Oncology +14

The oncogenic human B-cell lymphoma MYD88 L265P mutation genocopies activation by phosphorylation at the Toll/interleukin-1 receptor (TIR) domain

Marthe Minderman, Hildo C. Lantermans, Carmen van der Zwaan et al. · Blood Cancer Journal · 2023 · 13 citations · Full text

Life Sciences, Immunology, Oncology +16

1–4 of 4